Begin main content

Calls for Patient Input: Ozanex, Nitisinone and Lapelga

Published on: December 14, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

nitisinone

Brand name Generic name Manufacturer Indication(s)
Nitisinone nitisinone Cycle Pharmaceuticals Ltd. Hereditary tyrosinemia type 1
Project Number Call for patient input Patient input deadline Submit patient input
SR0554-000 2017-12-14 2018-02-09 Submit

pegfilgrastim

Brand name Generic name Manufacturer Indication(s)
Lapelga pegfilgrastim Apobiologix Febrile neutropenia, prevention or treatment
Project Number Call for patient input Patient input deadline Submit patient input
SE0555-000 2017-12-14 2018-02-09 Submit

ozenoxacin

Brand name Generic name Manufacturer Indication(s)
Ozanex ozenoxacin Cipher Pharmaceuticals Inc. Impetigo
Project Number Call for patient input Patient input deadline Submit patient input
SR0553-000 2017-12-14 2018-02-09 Submit